Liu et al. found that knockdown of PRMT5 in colorectal cancer cells can reduce the accumulation of H4R3me2s and H3R8me2s markers, and reduce the CpG methylation level of cyclin dependent kinase inhibitor 2B promoter (Yang et al., 2021). Here, PRMT5 is linked to colorectal cancer.